Search company, investor...

Predict your next investment

Venture Capital
maidenlane.com

Investments

31

Portfolio Exits

8

Funds

2

About Maiden Lane

Maiden Lane Ventures was formed to invest in syndicates launched through AngelList. Syndicate backers can pledge a percentage of each investment it makes or put a set amount of money in each one.

Headquarters Location

16 Maiden Lane Suite 600

San Francisco, California, 94108,

United States

415-590-2478

Want to inform investors similar to Maiden Lane about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Maiden Lane News

Concord buys Cambria Chelsea hotel for $48M

Mar 25, 2023

A Concord Hospitality appears to be taking over ownership of a Manhattan hotel the firm has managed for the last eight years. An entity connected to the Raleigh-based hotel management and development company acquired the Cambria Chelsea hotel at 123 West 28th Street for $48.4 million from Robert Chun’s We Care Trading Co. Ltd, according to property records filed Thursday. Concord financed the acquisition with a $32.5 million loan from Western Alliance Bank. PincusCo was first to report on the transaction. The property was last sold in 1994 for an undisclosed amount. Concord did not respond to a request for comment. Choice Hotels International broke ground on the 135-key Cambria Chelsea in 2012, and the 18-floor hotel opened three years later. Concord operated the hotel , but the 55,400-square-foot property was owned by Chun’s We Care Trading Co. Ltd. Concord has been an active player in Manhattan’s hotel market in recent years. The company sold the 21-floor, 196-key, 126,000-square-foot Cambria Times Square hotel at 30 West 46th Street in 2021 for $89 million after buying the parcel in 2013 for $30 million. Concord acquired the Courtyard Marriott hotel at 100 Greenwich Street in Lower Manhattan in 2021 for $69 million from Sam Chang’s McSam Hotel Group. The firm’s North American hotel and hospitality portfolio also includes the AC Hotel at 151 Maiden Lane in the Financial District, as well as several properties across South Florida and Texas. Concord’s acquisition comes as Manhattan’s hotel market, beleaguered over the past three years by the pandemic, appears to be showing some signs of recovery. New York City saw $2.05 billion in hotel deal volume last year, its highest since the onset of the pandemic, according to JLL Research. However, that metric is still far below pre-pandemic levels of $2.69 billion in 2018 and $2.59 billion in 2019. Revenue per available room increased 54 percent year-over-year in the fourth quarter, pushing past pre-pandemic levels for the first time in the second half of last year as daily room rates rose and both tourism and business travel picked up, according to PWC’s Manhattan lodging index . The trend was consistent across both large chain and boutique hotels, as well as full and limited-service properties. Read more A Concord Hospitality appears to be taking over ownership of a Manhattan hotel the firm has managed for the last eight years. An entity connected to the Raleigh-based hotel management and development company acquired the Cambria Chelsea hotel at 123 West 28th Street for $48.4 million from Robert Chun’s We Care Trading Co. Ltd, according to property records filed Thursday. Concord financed the acquisition with a $32.5 million loan from Western Alliance Bank. PincusCo was first to report on the transaction. The property was last sold in 1994 for an undisclosed amount. Concord did not respond to a request for comment. Choice Hotels International broke ground on the 135-key Cambria Chelsea in 2012, and the 18-floor hotel opened three years later. Concord operated the hotel , but the 55,400-square-foot property was owned by Chun’s We Care Trading Co. Ltd. Concord has been an active player in Manhattan’s hotel market in recent years. The company sold the 21-floor, 196-key, 126,000-square-foot Cambria Times Square hotel at 30 West 46th Street in 2021 for $89 million after buying the parcel in 2013 for $30 million. Concord acquired the Courtyard Marriott hotel at 100 Greenwich Street in Lower Manhattan in 2021 for $69 million from Sam Chang’s McSam Hotel Group. The firm’s North American hotel and hospitality portfolio also includes the AC Hotel at 151 Maiden Lane in the Financial District, as well as several properties across South Florida and Texas. Concord’s acquisition comes as Manhattan’s hotel market, beleaguered over the past three years by the pandemic, appears to be showing some signs of recovery. New York City saw $2.05 billion in hotel deal volume last year, its highest since the onset of the pandemic, according to JLL Research. However, that metric is still far below pre-pandemic levels of $2.69 billion in 2018 and $2.59 billion in 2019. Revenue per available room increased 54 percent year-over-year in the fourth quarter, pushing past pre-pandemic levels for the first time in the second half of last year as daily room rates rose and both tourism and business travel picked up, according to PWC’s Manhattan lodging index . The trend was consistent across both large chain and boutique hotels, as well as full and limited-service properties. Read more

Maiden Lane Investments

31 Investments

Maiden Lane has made 31 investments. Their latest investment was in Dyspatch as part of their Series A on November 11, 2017.

CBI Logo

Maiden Lane Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/21/2017

Series A

Dyspatch

$5M

No

13

1/25/2017

Series A

Teachable

$4M

No

4

6/22/2016

Series A

Try Technologies

$5.46M

Yes

1

4/21/2016

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

3/31/2016

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/21/2017

1/25/2017

6/22/2016

4/21/2016

3/31/2016

Round

Series A

Series A

Series A

Seed VC

Seed VC

Company

Dyspatch

Teachable

Try Technologies

Subscribe to see more

Subscribe to see more

Amount

$5M

$4M

$5.46M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

13

4

1

10

10

Maiden Lane Portfolio Exits

8 Portfolio Exits

Maiden Lane has 8 portfolio exits. Their latest portfolio exit was Teachable on March 16, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/16/2020

Acquired

$99M

3

11/25/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/22/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/27/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

10/30/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/16/2020

11/25/2019

5/22/2019

2/27/2019

10/30/2017

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Maiden Lane Fund History

2 Fund Histories

Maiden Lane has 2 funds, including Maiden Lane Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/15/2014

Maiden Lane Fund I

Fund Of Funds

Closed

3

Maiden Lane Fund II

Subscribe to see more

Subscribe to see more

10

Closing Date

4/15/2014

Fund

Maiden Lane Fund I

Maiden Lane Fund II

Fund Type

Fund Of Funds

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

Sources

3

10

Maiden Lane Team

2 Team Members

Maiden Lane has 2 team members, including , .

Name

Work History

Title

Status

Jeff Fagnan

Atlas Venture, and Seed Capital Partners

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Jeff Fagnan

Subscribe to see more

Work History

Atlas Venture, and Seed Capital Partners

Title

Founder

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.